These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 25688657)

  • 21. Thrombin generation as objective parameter of treatment response in patients with severe haemophilia A and high-titre inhibitors.
    Luna-Záizar H; Beltrán-Miranda CP; Esparza-Flores MA; Soto-Padilla J; Bergés-García A; Rodríguez-Zepeda MD; Pompa-Garza MT; Jaloma-Cruz AR
    Haemophilia; 2014 Jan; 20(1):e7-14. PubMed ID: 24354488
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of action of immune tolerance induction against factor VIII in patients with congenital haemophilia A and factor VIII inhibitors.
    Reipert BM; van Helden PM; Schwarz HP; Hausl C
    Br J Haematol; 2007 Jan; 136(1):12-25. PubMed ID: 17222196
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Factor VIII-specific B cell responses in haemophilia A patients with inhibitors.
    van Helden PM; Van Haren SD; Fijnvandraat K; van den Berg HM; Voorberg J
    Haemophilia; 2010 May; 16(102):35-43. PubMed ID: 20536984
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Management of haemophilic pseudotumours with special emphasis on radiotherapy and arterial embolization.
    Espandar R; Heidari P; Rodriguez-Merchan EC
    Haemophilia; 2009 Mar; 15(2):448-57. PubMed ID: 19175421
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Haemophilic pseudotumours of the mandible: report of a case in a one-year-old child.
    Brook AH; Bedi R; Lui WY; Yuen PM
    Br J Oral Maxillofac Surg; 1985 Feb; 23(1):47-52. PubMed ID: 3156625
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Risk of inhibitor development in mild haemophilia A increases with age.
    Mauser-Bunschoten EP; Den Uijl IE; Schutgens RE; Roosendaal G; Fischer K
    Haemophilia; 2012 Mar; 18(2):263-7. PubMed ID: 21851507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Modulation of factor VIII-specific memory B cells.
    Reipert BM; Allacher P; Hausl C; Pordes AG; Ahmad RU; Lang I; Ilas J; Windyga J; Klukowska A; Muchitsch EM; Schwarz HP
    Haemophilia; 2010 May; 16(102):25-34. PubMed ID: 20536983
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pelvic haemophilic pseudotumour: management of a patient with high level of inhibitors.
    Keller A; Terrier F; Schneider PA; Bianchi S; Howarth N; De Moerloose P
    Skeletal Radiol; 2002 Sep; 31(9):550-3. PubMed ID: 12195512
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Occurrence of inhibitors in previously untreated or minimally treated patients with haemophilia A after exposure to a plasma-derived solvent-detergent factor VIII concentrate.
    Gringeri A; Monzini M; Tagariello G; Scaraggi FA; Mannucci PM;
    Haemophilia; 2006 Mar; 12(2):128-32. PubMed ID: 16476086
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Rituximab as a single agent in the management of adult patients with haemophilia A and inhibitors: marked reduction in inhibitor level and clinical improvement in bleeding but failure to eradicate the inhibitor.
    Aleem A; Saidu A; Abdulkarim H; Al-Diab AR; Al-Sagheer A; Qayum A; Al-Momen AK
    Haemophilia; 2009 Jan; 15(1):210-6. PubMed ID: 19149851
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Total joint replacement in patients with inhibitors.
    Solimeno LP; Perfetto OS; Pasta G; Santagostino E
    Haemophilia; 2006 Jul; 12 Suppl 3():113-6. PubMed ID: 16684005
    [TBL] [Abstract][Full Text] [Related]  

  • 32. European study on orthopaedic status of haemophilia patients with inhibitors.
    Morfini M; Haya S; Tagariello G; Pollmann H; Quintana M; Siegmund B; Stieltjes N; Dolan G; Tusell J
    Haemophilia; 2007 Sep; 13(5):606-12. PubMed ID: 17880451
    [TBL] [Abstract][Full Text] [Related]  

  • 33. New protocol for immune tolerance induction in acquired hemophilia.
    Nemes L; Pitlik E
    Haematologica; 2000 Oct; 85(10 Suppl):64-8. PubMed ID: 11187874
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characteristics and management of the haemophilia-associated pseudotumours.
    Doyle AJ; Back DL; Austin S
    Haemophilia; 2020 Jan; 26(1):33-40. PubMed ID: 31742871
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Influence of the type of F8 gene mutation on inhibitor development in a single centre cohort of severe haemophilia A patients.
    Gouw SC; Van Der Bom JG; Van Den Berg HM; Zewald RA; Ploos Van Amstel JK; Mauser-Bunschoten EP
    Haemophilia; 2011 Mar; 17(2):275-81. PubMed ID: 21070499
    [TBL] [Abstract][Full Text] [Related]  

  • 36. How to manage invasive procedures in children with haemophilia.
    Ljung RC; Knobe K
    Br J Haematol; 2012 Jun; 157(5):519-28. PubMed ID: 22390160
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Severe haemophilia A patients have reduced numbers of peripheral memory B cells.
    Irigoyen MB; Felippo ME; Primiani L; Candela M; Bianco RP; De Bracco MM; Galassi N
    Haemophilia; 2012 May; 18(3):437-43. PubMed ID: 21910787
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Surgical treatment of the haemophilic pseudotumour: a single centre experience.
    Panotopoulos J; Ay C; Trieb K; Funovics PT; Stockhammer V; Lang S; Holinka J; Windhager R; Pabinger I; Wanivenhaus HA
    Int Orthop; 2012 Oct; 36(10):2157-62. PubMed ID: 22752668
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Frequency of factor VIII (FVIII) inhibitor in haemophilia A.
    Borhany M; Kumari M; Shamsi T; Naz A; Farzana T
    J Coll Physicians Surg Pak; 2012 May; 22(5):289-93. PubMed ID: 22538032
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Antibody formation and specificity in Bethesda-negative brother pairs with haemophilia A.
    Klintman J; Hillarp A; Donfield S; Berntorp E; Astermark J
    Haemophilia; 2013 Jan; 19(1):106-12. PubMed ID: 22762454
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.